Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 14)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: HOLLIS-EDEN PHAR -- HEPH1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS3$4  View Abstract
11-Nov-09DatamonitorDatamonitor PLCHollis-Eden Pharmaceuticals, Inc. - Company Profile16$50  View Abstract
6-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Hollis-Eden Pharmaceuticals, Inc.42$65  View Abstract
4-Nov-09Global Markets DirectGlobal Markets DirectHollis-Eden Pharmaceuticals, Inc. Financial and Strategic Analysis Review18$300  View Abstract
27-Oct-09EconomicInvestorN/A"The Economy Matters" Report for HEPH: the economy's impact on HEPH's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for BIOTECHNOLOGY18$49  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for HEPH13$25  View Abstract
Next 4

Independent Reports (Showing 1 to 10 of 14)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: HOLLIS-EDEN PHAR -- HEPH1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS3$4View Abstract
11-Nov-09DatamonitorDatamonitor PLCHollis-Eden Pharmaceuticals, Inc. - Company Profile16$50View Abstract
6-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Hollis-Eden Pharmaceuticals, Inc.42$65View Abstract
4-Nov-09Global Markets DirectGlobal Markets DirectHollis-Eden Pharmaceuticals, Inc. Financial and Strategic Analysis Review18$300View Abstract
27-Oct-09EconomicInvestorN/A"The Economy Matters" Report for HEPH: the economy's impact on HEPH's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for BIOTECHNOLOGY18$49View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for HEPH13$25View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.